Hamilton Beach (HBB) family trust granted 1,431 Class A shares in equity award
A recent Form 4 filing for Hamilton Beach Brands Holding Co (HBB) reported that a family trust associated with David B. Williams received 1,431 Class A Common Stock shares as an equity award. These "Required Shares" were granted under the company's Non-Employee Directors' Equity Compensation Plan at a price of $0.00 per share. Following this transaction, the spouse-benefit trust now holds 207,196 Class A shares, though Williams disclaims beneficial ownership of all these shares.
Simon Property Group director Leibowitz acquires $113,475 of common stock
Simon Property Group director Reuben S. Leibowitz acquired $113,475 worth of the company's common stock on June 30, 2026, purchasing 508 shares through dividend reinvestment. These transactions occurred as the stock trades near its 52-week high, having delivered a 42.6% return over the past year. The company (SPG) maintains a 4% dividend yield and has a 33-year history of dividend payments, with analysts holding mixed sentiments on its valuation following recent earnings and a downgrade by Wolfe Research balanced by an upgrade from Argus.
GPK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Graphic Packaging Holding Company Shareholders Have Opportunity to Lead Class Action Lawsuit!
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Graphic Packaging Holding Company (NYSE:GPK) and its officers. The lawsuit alleges that the company made materially false and misleading statements about its business operations and prospects, specifically regarding inventory issues, reduced demand, and increased costs, which negatively impacted its financial results. Shareholders who purchased GPK securities between February 4, 2025, and February 2, 2026, are encouraged to join the lawsuit, with a deadline of July 6, 2026, to request lead plaintiff status.
GreenPower Announces Completion of Third Tranche of Preferred Share Financing
GreenPower Motor Company Inc. announced the completion of the third tranche of its Series A Convertible Preferred Share financing, raising US$1,425,000 in gross proceeds. The company also amended its agreement with the institutional investor to increase the aggregate stated value of issuable preferred shares by an additional US$2 million. These preferred shares are convertible into common shares based on a specified conversion rate.
T. Rowe Price (TROW) Ascends While Market Falls: Some Facts to Note
T. Rowe Price (TROW) stock recently rose by 2.13% while the broader market declined, outperforming the S&P 500, Dow, and Nasdaq. Over the last month, TROW shares have increased by 8.99%, surpassing both its sector and the S&P 500. Analysts anticipate T. Rowe Price to report earnings of $2.35 per share and revenue of $1.89 billion in its upcoming release, indicating positive year-over-year growth.
Form 4 Establishment Labs Holdings Inc For: 1 July By Investing.com
This article announces the filing of a Form 4 for Establishment Labs Holdings Inc. for July 1st. It provides various financial market data including indices, commodities, and trending stocks, indicating that this is a routine financial disclosure by the company.
Driven Brands Holdings (DRVN) grants CLO 57,252 RSUs vesting through 2029
O'Melia Scott L., the Chief Legal Officer of Driven Brands Holdings (DRVN), was granted 57,252 restricted stock units (RSUs). These RSUs will vest in three equal installments on March 11, 2027, March 11, 2028, and March 11, 2029, contingent on his continued employment. Following this award, O'Melia Scott L. now holds a total of 375,415 shares of Common Stock directly.
Form 4 Driven Brands Holdings Inc For: 1 July By Investing.com
The article reports on a Form 4 filing for Driven Brands Holdings Inc. on July 1st. It also includes general market data, popular news articles, and various financial instruments/indices, indicating it's a standard financial news update from Investing.com.
West Pharmaceutical (WST) director awarded new phantom stock units and RSUs
West Pharmaceutical Services Inc. director Janet Brutschea Haugen has been awarded 46 new Phantom Stock Units and holds 791 restricted stock units (RSUs) and dividend equivalents. This compensation, which will be settled in stock upon her termination as a director for phantom units and vest at the next annual shareholder meeting for RSUs, increases her total phantom unit balance to 306.678 and reinforces her alignment with shareholder interests. The Form 4 filing details these routine equity-based awards, indicating no open-market stock purchases or sales.
Form 4 West Pharmaceutical Services Inc For: 1 July By Investing.com
This article from Investing.com reports the filing of a Form 4 by West Pharmaceutical Services Inc. on July 1st. The filing pertains to West Pharmaceutical Services (WST), which saw a 1.71% increase in its stock value.


